Результаты поиска

Микробиота и почки в Камеруне работают в автосомных доминирующих полициклических болезнях почек: перекрестное исследование.

Гут дисбиоз патобионтов (Enterobacter, Eschericia и Salmonella) и симбионтов (Bifidobacterium, Lactobacillus и Prevotella) может происходить во время развития хронической болезни почек (CKD). Мы провели оценку связей между репрезентативными симбионтами (Bifidobacterium и Lactobacillus) и патобионтами (Enterobacteriaceae) с функцией почек у лиц с автосомальным доминирующим полициклическим заболеванием почек (ADPKD). МЕТОДЫ: В этом перекрестном исследовании 29 Пациенты ADPKD сравнивались с пациентами 15 контроля в районе действия 2::1 соотношение. Были собраны клинические данные и биологические

Совпадение в полном тексте источника
… Subjects were excluded from the ADPKD group if they (1) had diabetes, chronic diarrhea, or chronic infections (HIV, hepatitis B or C); (2) had undergone hemodialysis; (3) were on antibiotics, prebiotics, probiotics, laxatives or NSAIDs in the last four weeks prior to enrolment, or (4) did not provide …

Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study.

BACKGROUND: A third of patients with advanced cancer and bone metastasis suffer from cancer induced bone pain (CIBP), impeding quality of life, psychological distress, depression and anxiety. This study will evaluate the impact of an opioid rotation, comparing methadone rotation with other opioid rotation in patients with refractory CIBP. METHODS: This open-label randomised controlled trial will recruit cancer patients with CIBP and inadequate pain control despite established baseline opioid and/or intolerable opioid side effects from cancer and palliative care services. Participants will be

Совпадение в полном тексте источника
… Adjustment to laxatives and other drugs used for usual symptom benefit are permitted. Participants will remain as an in-patient until stable opioid dose is achieved (a stable dose is defined when worst pain intensity is less than 4/10, with acceptable adverse effects (CTCAE grade < 2). …

The Effect of a High-Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma.

Ixazomib is the first oral proteasome inhibitor to be investigated in the clinic. This clinical study assessed whether the pharmacokinetics of ixazomib would be altered if administered after a high-calorie, high-fat meal. In a 2-period, 2-sequence, crossover study design, adult patients with advanced solid tumors or lymphoma received a 4-mg oral dose of ixazomib as immediate-release capsules on day 1 without food (fasted, administered following an overnight fast) or with food (fed, following consumption of a high-calorie, high-fat meal), followed by another dose on day 15 in the alternate food

Совпадение в полном тексте источника
… The most frequently reported concomitant medications were opioids (71%), laxatives (71%), antiemetics and antinauseants (63%), other analgesics and antipyretics (63%), vitamins A and D, including combinations of the two (54%), nonsteroidal anti‐inflammatory and antirheumatic products (54%), and intravenous …

Медицинский каннабис и признаки рака: критический обзор.

Онкология остаётся сложным и гетерогенным заболеванием, вызывающим значительную morbidity и mortality по всему миру, несмотря на продвижение в диагностике и лечении. Характерные черты онкологии раскрывают биологические механизмы, поддерживающие развитие опухолей и злокачественное эволюцию, а также помогают выявить потенциальные мишени для терапии. Медикаментозный кресс-масло в основном используется в онкологии для поддерживающей терапии, но растущее предклиническое доказательство указывает на взаимодействие с сигнальными путями, связанными с онкологией. Этот обзорный материал обобщает текущие

Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma.

Multiple myeloma (MM) is a very heterogeneous disease with multiple symptoms and clinical manifestations. MM affects mainly elderly patients and is difficult to manage in the presence of comorbidities, polypharmacy, frailty and adverse events of disease-targeted drugs. The rapid changes in MM treatment resulting from constant innovations in this area, together with the introduction of numerous new drugs with distinct mechanisms of action and toxicity profiles, have led to an increased complexity in the therapeutic decision-making and patient management processes. The prolonged exposure to nove

Совпадение в полном тексте источника
… Concomitant prescription of antiemetics and laxatives is advised ( 68 , 75 ). Given the mixed etiology of pain in MM patients, a multimodal approach is the most appropriate. … Dietary measures and laxatives are useful in these situations ( 68 , 105 ). Diarrhea is also a symptom frequently associated with bortezomib and ixazomib (in up to 45% of patients) ( 106 ) and occurs on the day of administration or the following day ( 107 ). …

Allergy in Cancer Care: Antineoplastic Therapy-Induced Hypersensitivity Reactions.

As the backbone of oncological treatments, systemic chemotherapy is still one of the main pawns in cancer care, alone or in combination with newer targeted agents. All chemotherapy agents can be associated with a type of adverse event called an infusion reaction, which can be characterized as unpredictable, non-dose related, and unexplained by the cytotoxic profile of the drug. For some of these events, a certain immunological mechanism can be identified by blood or skin testing. In this case, we can speak of true hypersensitivity reactions that occur as a response to an antigen/allergen. The

Menstrual patterns and gonado-sexual health following hematopoietic transplant in reproductive age women and the role of hormone replacement therapy.

BackgroundMenstrual patterns, reproductive sequelae, sexual health, and the role of hormone replacement therapy (HRT) among women following hematopoietic stem cell transplantation (HSCT) remain underexplored. This study evaluated menstrual resumption, ovarian reserve, fertility outcomes, sexual function, and attitudes towards HRT among women who underwent HSCT.MethodsThis single-centre retrospective, cross-sectional analysis included women aged 18-45 years who had undergone HSCT for haematological malignancies and were on follow-up of at least 6 months post-HSCT. Data collected encompassed dem

Keyword Index for Volume 90

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Qualitative study of kinesiophobia in patients with tumors after PICC catheterization.

To explore the kinesiophobia experience of patients with tumors after PICC catheterization and to analyze patients' views and true inner feelings about kinesiophobia, with the goal of providing a reference for reducing the occurrence of kinesiophobia and enhancing the experience of patients undergoing this procedure. A purposive sampling method was used to select patients with tumors that required the placement of a PICC line in a tertiary hospital in Ningbo City, Zhejiang Province, as the research object. A semistructured in-depth interview method was used for data collection, and the content

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Medication self-management behaviors of adolescents and young adults with cancer.

PurposeAdolescents and young adults (AYAs) with cancer are challenged to manage complex medication regimens during treatment. The aims of the study are to (1) describe the medication self-management behaviors of AYAs with cancer and (2) examine the barriers and facilitators to AYAs' optimal use of medications, including their self-efficacy to manage medications.MethodsThis cross-sectional study enrolled 30 AYAs (18-29 years) with cancer who were receiving chemotherapy. Participants electronically completed a demographic form, a health literacy screen, and the PROMIS Self-efficacy for Medicatio

Совпадение в полном тексте источника
… complications of cancer Antibiotics Antivirals Birth control agents Antifungals Gallstone solubilizing agents Anticoagulants Other b | 20 12 7 7 5 2 15 Prescribed for prevention/management of symptoms and side effects Antiemetics Supplements Analgesics Proton pump inhibitors Antihistamines Analgesics Laxatives …

Pattern of Adverse Drug Reactions Associated with the Use of Anticancer Drugs in an Oncology-Based Hospital of Nepal.

INTRODUCTION: Adverse drug reactions (ADRs) are among the leading causes of morbidity and mortality worldwide. ADRs of anticancer drugs are ubiquitous. However, in Nepal, studies on chemotherapy-induced ADRs are scarce. Thus, this study aimed to assess the ADRs associated with the use of anticancer drugs and their management along with causality assessment and severity of ADRs. METHODS: A prospective cross-sectional observational and single-center study was conducted at Bhaktapur Cancer Hospital, Nepal, for 6 months. All the patients who fulfilled the study criteria were analyzed to identify

Совпадение в полном тексте источника
… Granulocyte colony-stimulating factor | 68 (66.6) Multivitamin mineral tablets | 57 (55.8) Analgesics | 34 (33.3) Antimicrobial agents | 27 (26.4) Laxatives | 25 (24.5) Corticosteroids | 24 (23.5) Appetite stimulant | 23 (22.5) IV mannitol, Potassium Chloride, Magnesium Sulphate | 15 (14.7) Probiotics …

Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study.

BACKGROUND: Pain is a common symptom in patients with multiple myeloma (MM). Many patients are dependent on analgesics and in particular opioids, but there is limited information on the impact of these drugs and their side effects on health-related quality of life (HRQoL). METHOD: In a cross-sectional study, semi-structured interviews were performed in 21 patients attending the hospital with symptomatic MM on pain medications. HRQoL was measured using items 29 and 30 of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30. RESULTS: Patients were able to recall a med

Совпадение в полном тексте источника
… Unfortunately, the evidence base for current management of OIC using conventional laxatives is poor [ 22 ]. Only the newer peripherally acting opioid antagonist drugs have been shown in large double-blind RCTs to be efficacious without compromising pain control [ 23 ]. …

Profile and Management of Toxicity of Selinexor and Belantamab Mafodotin for the Treatment of Triple Class Refractory Multiple Myeloma.

Treatment options are limited for multiple myeloma patients who have developed four/five drug-refractory disease. Selinexor (Sel) and belantamab mafodotin (belamaf) were recently approved by the US FDA for treatment of RRMM. The toxicity profile of these drugs is a concern since these agents are used in patients who have already undergone multiple lines of treatment. In this review, we discuss the toxicity profile and strategies for the management of toxicities of Sel and belamaf for the treatment of RRMM. We conducted a comprehensive literature search on PubMed, Embase, Cochrane, and Clinical

Совпадение в полном тексте источника
… Photophobia Management of Ocular toxicity: see Table 3 Dry Eyes Preservative free artificial tears Pyrexia/headache/arthralgia Acetaminophen/Ibuprofen Constipation Laxatives Epistaxis Correct underlying thrombocytopenia if severe Symptomatic management Acute kidney injury Fluid resuscitation can be inpatient … | | Photophobia | Management of Ocular toxicity: see Table 3 | | Dry Eyes | Preservative free artificial tears | | Pyrexia/headache/arthralgia | Acetaminophen/Ibuprofen | | Constipation | Laxatives | | Epistaxis | Correct underlying thrombocytopenia if severe Symptomatic management | | Acute …

Саркопания у пожилых пациентов с новой диагностированной множественной миеломой.

UNLABELLED: <p>Introduction: Sarcopenia — это возрастное состояние, характеризующееся низкой массой мышц и низкой функциональностью, связанной с более низкими результатами. Его распространенность и прогнозируемая роль в миеломе (ММ) остаются неясными, поскольку в большинстве исследований речь идет лишь о мышечной массе, определяемой путем вычисления томографии (КТ) и игнорирования функции мышц. Цель этого исследования состояла в том, чтобы описать распространенность саркопсии по данным Европейской рабочей группы по саркопии среди пожилых людей. 2 (EUGSOP2) определение у пожилых пациентов с MM

Совпадение в полном тексте источника
… Geriatric syndromes such as malnutrition (GLIM criteria [ 22 ]), falls (number of falls in the last year [ 23 ]), and polypharmacy [ 24 ], defined as the consumption of ≥5 drugs, considering eye drops, laxatives, and over-the-counter, were assessed. …

The UK's Early Access to Medicines Scheme 10 years on: an evaluation using publicly available data.

ObjectivesTo investigate the drugs and indications that have passed through the UK's Early Access to Medicines Scheme (EAMS) to date, the type of evidence the regulator considers when accepting a drug into the EAMS, and potential risks to patients.DesignAnalysis of publicly available data: MHRA Public Assessment Reports; Electronic Medicines Compendium database; interactive Drug Analysis Profiles database; Eudravigilance database.SettingUnited Kingdom.ParticipantsThe 51 'scientific opinions' available on the MHRA website in June 2024.Main outcome measuresPublic Assessment Reports, pharmacovigi

Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy.

BACKGROUND: Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma (NHL) in the United States and Europe. However, data on FL from Latin America are scant. AIMS: This study aims at better understand the clinical features, treatment patterns and outcomes of patients with FL in Chile. Of special interest was to evaluate POD24 as an adverse marker. METHODS AND RESULTS: We collected retrospective data from 722 patients 15 years or older diagnosed with FL and treated in 17 cancer centers in Chile between 2000 and 2019. Time to first treatment (TTFT), progression-free survival (

Fc Epsilon RI-Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients.

Atopic dermatitis (AD) is the most common chronic relapsing neuroinflammatory skin disease that is characterized by a complex and multifactorial pathophysiology. It reflects a profound interplay between genetic and environmental factors, and a recently disclosed neuroimmune dysregulation that drives skin barrier disruption, pruritus, and microbial imbalance. In terms of the key external environmental players that impact AD, air quality and itch severity linkage have been thoroughly researched. The impact of ambient air pollutants including particulate matter (PM) and AD pruritic exacerbation h

Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany.

The aim was to assess the incremental costs of chimeric antigen receptor (CAR) T-cell therapy (axicabtagene ciloleucel, tisagenlecleucel) compared with standard of care in adult patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) from the German third-party payer perspective. A budget impact model was established over a 6-year period. Estimation of the third-line population: partitioned survival model based on outcome data from peer-reviewed literature, a top-down approach based on population forecasts, and age-standardized incidences. Cost data were derived from the

A Cost Impact Analysis of clonoSEQ® as a Valid and CE-Certified Minimal Residual Disease (MRD) Diagnostic Compared to No MRD Testing in Multiple Myeloma in Germany.

IntroductionThe measurement of minimal residual disease (MRD) with clonoSEQ® can be used in the assessment of B-cell lymphoid tumor burden throughout treatment with accuracy, sensitivity and standardization when compared to traditional cytomorphology. With the approval of novel treatments, standardized MRD assessment with improved performance is increasingly important. The aim of this analysis is to estimate the cost-effectiveness of MRD testing with clonoSEQ® compared to no MRD testing for patients with multiple myeloma (MM) on maintenance therapy in Germany.MethodsThe cost impact of clonoSEQ